BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.0%
5Y CAGR+17.3%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+22.0%/yr
vs +33.9%/yr prior
5Y CAGR
+17.3%/yr
Recent acceleration
Acceleration
-11.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.07B+31.5%
2024$814.88M+32.1%
2023$616.67M+4.5%
2022$589.85M-8.7%
2021$646.35M+33.9%
2020$482.73M+57.3%
2019$306.80M+67.0%
2018$183.66M+318.8%
2017$43.86M-